Funded Tech Companies

Mid-Atlantic Biotherapeutics

Mid-Atlantic Biotherapeutics is a biopharmaceutical company, located in Doylestown. Venture investment and financing was provided by Legend Innovation Life Science Fund.

Company Overview

Company Name
Mid-Atlantic Biotherapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
3805 Old Easton Road
Doylestown, PA 18902
USA
Phone
Undisclosed
Email Address
Not Recorded

Company Background Information

Overview
MABT was founded in 2011 with the simple goal of making a meaningful difference on the lives of patients, families and communities worldwide. We are especially excited about our work on neurodegenerative conditions such as Alzheimer's, Parkinson's and ALS. Mid-Atlantic BioTherapeutics is committed to pushing the boundaries of scientific understanding and therapeutic efficacy to address an unmet need for diseases that are hard to treat. By leveraging the power of biotechnology and artificial intelligence, we believe that we may be able to treat currently incurable diseases.
Profile
Mid-Atlantic Biotherapeutics LinkedIn Company Profile
Social Media
Mid-Atlantic Biotherapeutics Company Twitter Account
Company News
Mid-Atlantic Biotherapeutics News
Facebook
Mid-Atlantic Biotherapeutics on Facebook
YouTube
Mid-Atlantic Biotherapeutics on YouTube
Last Transaction
8/28/2025

Financing History

Date
Type
Amount
Venture Equity
$50,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
David Horn
  David Horn LinkedIn Profile  David Horn Twitter Account  David Horn News  David Horn on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

MID Labs | Midas

 

Share this article

 


About Our VC Funding Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary